期刊文献+

HIV-1膜抗原部分糖基化位点改造对免疫原性及假病毒形成的影响 被引量:2

The impact of site-dlrected deglycosylation of the HIV-1 envelope (Env) on its immunogenicity and assembly of functional pseudovirus
原文传递
导出
摘要 目的研究HIV-1膜蛋白(Env)特定糖基化位点改造对Env免疫原性及功能性假病毒形成能力的影响。方法采用环形诱变,DpnⅠ筛选的方法对Env进行定点突变,单周期感染试验检测功能性假病毒形成能力,免疫小鼠,利用假病毒中和试验与ELISPOT分别检测突变对中和抗体和T细胞分泌Env特异的IFN-γ的影响。结果N197Q突变体使Env诱导中和抗体的能力提高而诱导T细胞分泌Env特异的IFN-γ的能力降低,并使Env不能形成功能性假病毒;G2突变体(N624Q,N637Q)诱导的中和抗体能更好地中和假病毒74-2,但中和假病毒Wt的能力下降,对Env诱导T细胞分泌Env特异的IFN-γ的能力和功能性假病毒形成无明显影响。结论特定糖基化位点的改造影响假病毒的形成及Env的免疫原性。 Objective To study the influence of site-directed deglycosylation of the HIV-1 envelope (Env) on its immunogenicity and assembly of functional pseudovirus. Methods Site-directed deglycosylation were performed using cycling mutagenesis and selection of mutants with Dpn Ⅰ. Single-cycle infection assay was employed to analyze the effect of the mutations on the ability of functional pseudovirus assembly. The influence of deglycosylations on the immunodeficiency of Env was evaluated using pseudovirusbased neutralization assay and ELISPOT assay. Results Mutant N197Q induced higher neutralization activities for both pseudoviruses, but lower Env-specific T-cell response. And N197Q rendered the Env to lose the ability of functional pseudovirus assembly. Mutant G2 induced higher neutralization activities for pseudovirus 74-2 but lower for pseudovirus Wt, and had almost no influence on Env-specific T-cell response and functional pseudovirus forming. Conclusion The site-directed deglycosylation of the HIV-1 Env affects the pseudovirus forming and its immunogenicity.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2008年第6期540-544,共5页 Chinese Journal of Microbiology and Immunology
关键词 HIV-1 免疫原性 中和试验 去糖基化 ELISPOT HIV-1 Immunogenicity Neutralization assay Deglycosylation ELISPOT
  • 相关文献

参考文献14

  • 1Kwong PD, Wyatt R, Robinson J, et al. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature, 1998, 393(6686) : 648- 659.
  • 2Chen Z, Huang Y, Zhao X, et al. Enhanced infectivity of an R5tropic simian/human immunodeficiency virus carrying human immunodeficiency virus type 1 subtype C envelope after serial passages in pig-tailed macaques (Macaca nemestrina). J Virol, 2000, 74(14) : 6501-6510.
  • 3Weiner MP, Costa GL. Rapid PCR site-directed mutagenesis. PCR Methods Appl, 1994, 4(3) : S131-S136.
  • 4Evans DT, O'Connor DH, Jing P, et al. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat Med, 1999, 5 ( 11 ) : 1270-1276.
  • 5Lacks S, Greenberg B. A deoxyribonuclease of Diplococcus pneumoniae specific for methylated DNA. J Biol Chem, 1975, 250 ( 11 ) : 4060-4066.
  • 6Geier GE, Modrich P. Recognition sequence of the dam methylase of Escherichia coli K12 and mode of cleavage of Dpn I endonuclease. J Biol Chem, 1979, 254(4) : 1408-1413.
  • 7Gzyl J, Bolesta E, Wierzbicki A, et al. Effect of partial and complete variable loop deletions of the human immunodeficiency virus type 1 envelope glycoprotein on the breadth of gp160-specific immune responses. Virology, 2004, 318(2) : 493-506.
  • 8Huang CC, Tang M, Zhang MY, et al. Structure of a V3-containing HIV-1 gp120 core. Science, 2005, 310 (5750) : 1025- 1028.
  • 9Chan DC, Fass D, Berger JM, et al. Core structure of gp41 from the HIV envelope glycoprotein. Cell, 1997, 89(2) : 263-273.
  • 10Amara RR, Smith JM, Staprans SI, et al. Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine. J Virol, 2002, 76(12) : 6138-6146.

二级参考文献6

  • 1McCaffrey RA,Saunders C,Hensel M,et al.N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp 120and anti-gp41 antibodies.J Virol,2004,78(7):3279-3295.
  • 2Kolchinsky P,Kiprilov E,Bartley P,et al.Loss of a single N-linked glycan allows CD4 independent human immunodeficiency virus type 1 infection by altering the position of the gp120 V1/V2 variable loops.J Virol,2001,75(7):3435-3443.
  • 3Ly A,Stamatatos L.V2 Loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.J Virol,2000,74(15):6769-6776.
  • 4Scanlan CN,Pantophlet R,Wormald MR,et al.The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of α1→2 mannose residues on the outer face of gp120.J Virol,2002,76(14):7306-7321.
  • 5Rizzuto CD,Wyatt R,Hemandez-Ramos N,et al.Conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.Science,1998,280(5371):1949-1953.
  • 6Reitter JN,Means RE,Desrosiers RC.A role for carbohydrates in immune evasion in AIDS.Nat Med,1998,4(6):679-684.

共引文献3

同被引文献19

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部